93 related articles for article (PubMed ID: 12871726)
1. Enhanced expression of uridine diphosphate-N-acetylglucosaminyl transferase (OGT) in a stable, tetracycline-inducible HeLa cell line using histone deacetylase inhibitors: kinetics of cytosolic OGT accumulation and nuclear translocation.
Marshall S; Duong T; Wu T; Hering MA; Yada J; Higgins S; Orbus RJ; Yan ZH; Rumberger JM
Anal Biochem; 2003 Aug; 319(2):304-13. PubMed ID: 12871726
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of vanadate on UDP-N-acetylglucosaminyl transferase activity derived from cytosol and nucleosol.
Marshall S; Okuyama R
Biochem Biophys Res Commun; 2004 Jun; 318(4):911-5. PubMed ID: 15147958
[TBL] [Abstract][Full Text] [Related]
3. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme.
Okuyama R; Marshall S
J Neurochem; 2003 Sep; 86(5):1271-80. PubMed ID: 12911634
[TBL] [Abstract][Full Text] [Related]
4. Potential regulation of nuclear UDP-N-acetylglucosaminyl transferase (OGT) by substrate availability: ability of chromatin protein to bind UDP-N-acetylglucosamine and reduce OGT-mediated O-Linked glycosylation.
Okuyama R; Marshall S
Biol Pharm Bull; 2004 Aug; 27(8):1293-6. PubMed ID: 15305040
[TBL] [Abstract][Full Text] [Related]
5. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.
Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI
Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882
[TBL] [Abstract][Full Text] [Related]
6. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats.
Kreppel LK; Hart GW
J Biol Chem; 1999 Nov; 274(45):32015-22. PubMed ID: 10542233
[TBL] [Abstract][Full Text] [Related]
7. Measurement of UDP-N-acetylglucosaminyl transferase (OGT) in brain cytosol and characterization of anti-OGT antibodies.
Marshall S; Duong T; Orbus RJ; Rumberger JM; Okuyama R
Anal Biochem; 2003 Mar; 314(2):169-79. PubMed ID: 12654302
[TBL] [Abstract][Full Text] [Related]
8. Turnover and characterization of UDP-N-acetylglucosaminyl transferase in a stably transfected HeLa cell line.
Marshall S; Okuyama R; Rumberger JM
Biochem Biophys Res Commun; 2005 Jun; 332(1):263-70. PubMed ID: 15896326
[TBL] [Abstract][Full Text] [Related]
9. Suppression of caspase-11 expression by histone deacetylase inhibitors.
Heo H; Yoo L; Shin KS; Kang SJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432
[TBL] [Abstract][Full Text] [Related]
10. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
12. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
13. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
Garcia-Villalba P; Jimenez-Lara AM; Castillo AI; Aranda A
DNA Cell Biol; 1997 Apr; 16(4):421-31. PubMed ID: 9150429
[TBL] [Abstract][Full Text] [Related]
14. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
McBain JA; Eastman A; Nobel CS; Mueller GC
Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
[TBL] [Abstract][Full Text] [Related]
18. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.
Shao Y; Gao Z; Marks PA; Jiang X
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18030-5. PubMed ID: 15596714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
